Literature DB >> 11922706

Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas.

S B Wharton1, K K Chan, I R Whittle.   

Abstract

The expression of neuronal antigens in diffuse astrocytomas has not been thoroughly evaluated. We have investigated the expression of microtubule associated protein 2 (MAP-2), synaptophysin and non-phosphorylated epitopes of neurofilament protein (NFP) by immunohistochemistry in 15 low grade diffuse astrocytomas and 15 glioblastomas. MAP-2 was strongly expressed in 97% of cases, using an antibody to both low and high molecular weight isoforms. An antibody specific to high molecular weight isoforms of MAP-2 (hmw-MAP-2) revealed weaker, focal staining in 60% of cases with greater expression in the glioblastomas (P=0.027). NFP was expressed in 50% of cases, but was generally weak and focal. There was little evidence of synaptophysin expression. We conclude that MAP-2 expression in astrocytomas is due predominantly to low molecular weight isoforms, which may be expressed in astrocytes as well as neurons. Focal expression of hmw-MAP-2 and NFP, however, suggest that neuronal antigens may be expressed, particularly in high grade astrocytomas. Immunopositivity for these antigens should not preclude the diagnosis of diffuse astrocytoma. Copyright 2002, Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11922706     DOI: 10.1054/jocn.2001.1055

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  9 in total

1.  A unique model system for tumor progression in GBM comprising two developed human neuro-epithelial cell lines with differential transforming potential and coexpressing neuronal and glial markers.

Authors:  Anjali Shiras; Arti Bhosale; Varsha Shepal; Ravi Shukla; V S Baburao; K Prabhakara; Padma Shastry
Journal:  Neoplasia       Date:  2003 Nov-Dec       Impact factor: 5.715

Review 2.  Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator.

Authors:  Wei Duan; Yu-Ping Zhang; Zhi Hou; Chen Huang; He Zhu; Chun-Qing Zhang; Qing Yin
Journal:  Mol Neurobiol       Date:  2015-02-14       Impact factor: 5.590

3.  Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.

Authors:  Annette Nørregaard; Stine Skov Jensen; Jesper Kolenda; Charlotte Aaberg-Jessen; Karina Garnier Christensen; Poul Henning Jensen; Henrik Daa Schrøder; Bjarne Winther Kristensen
Journal:  Neurotox Res       Date:  2011-12-28       Impact factor: 3.911

4.  Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.

Authors:  Véronique Duhem-Tonnelle; Ivan Bièche; Sophie Vacher; Anne Loyens; Claude-Alain Maurage; Francis Collier; Marc Baroncini; Serge Blond; Vincent Prevot; Ariane Sharif
Journal:  J Neuropathol Exp Neurol       Date:  2010-06       Impact factor: 3.685

5.  Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex.

Authors:  Marjolein de Groot; Sjoukje T Toering; Karin Boer; Wim G M Spliet; Jan J Heimans; Eleonora Aronica; Jaap C Reijneveld
Journal:  Neuro Oncol       Date:  2010-01-06       Impact factor: 12.300

6.  Prognostic significance of neuronal marker expression in glioblastomas.

Authors:  Kyung-Hwa Lee; Kyung-Joo Kang; Kyung-Sub Moon; Tae-Young Jung; Shin Jung; Jae-Hyoo Kim; Hyung-Seok Kim; Min-Cheol Lee
Journal:  Childs Nerv Syst       Date:  2012-08-26       Impact factor: 1.475

7.  Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.

Authors:  Tao Yan; Kai Ove Skaftnesmo; Lina Leiss; Linda Sleire; Jian Wang; Xingang Li; Per Øyvind Enger
Journal:  BMC Cancer       Date:  2011-12-20       Impact factor: 4.430

Review 8.  The Cytoskeleton-A Complex Interacting Meshwork.

Authors:  Tim Hohmann; Faramarz Dehghani
Journal:  Cells       Date:  2019-04-18       Impact factor: 6.600

9.  Microtubule-Associated Protein 2 Expression in Canine Glioma.

Authors:  Elena Alina Demeter; Chad Frank; Daniel R Rissi; Brian F Porter; Andrew D Miller
Journal:  Front Vet Sci       Date:  2019-11-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.